iSpecimen (ISPC) Liabilities and Shareholders Equity (2020 - 2026)

iSpecimen's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $6.6 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 3.41% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $31.2 million (down 20.8% YoY), while the FY2025 annual figure was $9.5 million, up 1.94% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $6.6 million, down from $9.5 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $33.3 million in Q1 2022, with the low at $6.0 million in Q2 2025.
• The 5-year median for Liabilities and Shareholders Equity is $12.5 million (2024), against an average of $15.9 million.
• The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity soared 58.55% in 2022, then tumbled 49.3% in 2025.
• iSpecimen's Liabilities and Shareholders Equity stood at $24.6 million in 2022, then slumped by 35.74% to $15.8 million in 2023, then slumped by 40.89% to $9.4 million in 2024, then advanced by 1.94% to $9.5 million in 2025, then slumped by 30.65% to $6.6 million in 2026.
• Business Quant data shows ISPC's Liabilities and Shareholders Equity at $6.6 million in Q1 2026, $9.5 million in Q4 2025, and $9.0 million in Q3 2025.